SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Resmed Inc – ‘8-K’ for 4/26/16

On:  Tuesday, 4/26/16, at 4:05pm ET   ·   For:  4/26/16   ·   Accession #:  1193125-16-556414   ·   File #:  1-15317

Previous ‘8-K’:  ‘8-K’ on / for 4/4/16   ·   Next:  ‘8-K/A’ on 6/9/16 for 4/4/16   ·   Latest:  ‘8-K’ on / for 1/24/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/26/16  Resmed Inc                        8-K:2,8,9   4/26/16    2:154K                                   RR Donnelley/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     13K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     84K 


8-K   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 8-K  

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Under Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 26, 2016

 

 

ResMed Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-15317   98-0152841

(State or Other Jurisdiction of

Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

9001 Spectrum Center Blvd.

San Diego, California 92123

(Address of Principal Executive Offices)

(858) 836-5000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Disclosure of Results of Operations and Financial Condition.

On April 26, 2016 we issued the press release attached as Exhibit 99.1. It is incorporated into this report by reference. The press release describes the results of our operations for the quarter ended March 31, 2016.

Item 8.01. Other Events.

On April 26, 2016, we announced that our board of directors declared a quarterly cash dividend of US $0.30 per share of outstanding common stock. The dividend will be payable on June 16, 2016, with a record date of May 19, 2016. We will pay the dividend in US currency to holders of our common stock trading on the New York Stock Exchange (NYSE). We will pay the dividend to holders of CHESS Depositary Instruments (CDIs) trading on the Australian Securities Exchange (ASX) at an equivalent amount in Australian currency, based on the exchange rate on May 19, 2016, and reflecting the 10:1 ratio between CDIs and NYSE shares. The ex-dividend date will be May 17, 2016 for CDI holders and common stock holders. ResMed has received a waiver from the ASX’s settlement operating rules, which will allow us to defer processing conversions between its common stock and CDI registers from May 18, 2016 through May 19, 2016, inclusive.

Item 9.01. Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibits:

  

Description of Document

99.1    Press Release dated April 26, 2016 regarding results of operations

 

2


SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: April 26, 2016     RESMED INC.
    (registrant)
    By:  

/s/ Brett Sandercock

    Name: Brett Sandercock
    Its: Chief Financial Officer

 

3


EXHIBIT INDEX

 

Exhibits:

  

Description of Document

99.1    Press Release dated April 26, 2016 regarding results of operations

Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
6/16/16None on these Dates
5/19/16
5/18/16
5/17/16
Filed on / For Period End:4/26/16
3/31/16
 List all Filings 
Top
Filing Submission 0001193125-16-556414   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 9:29:46.1am ET